Combined data from five implantable cardioverter-defibrillator (ICD) trials suggest that it is the underlying arrhythmic disorder, rather than the ICD therapy itself, that affects mortality in these ...
Of the 298 subjects who were enrolled, 14 were exited from the study prior to implant (four withdrew consent prior to the implant procedure, the protocol was disallowed by insurance carriers in six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results